e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Severity, comorbidities and outcomes in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late-breaking abstract: CAP, HCAP and immunocompromised patients with pneumonia: Should we rethink the concepts?
M. Carrabba, M. Zarantonello, C. Hu, P. Bonara, G. Fabio (Milano, Italy)
Source:
Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia
Session:
Severity, comorbidities and outcomes in community-acquired pneumonia
Session type:
Oral Presentation
Number:
4706
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Carrabba, M. Zarantonello, C. Hu, P. Bonara, G. Fabio (Milano, Italy). Late-breaking abstract: CAP, HCAP and immunocompromised patients with pneumonia: Should we rethink the concepts?. Eur Respir J 2011; 38: Suppl. 55, 4706
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Late-breaking abstract: The differences in clinical presentations between severe health care-associated pneumonia and severe community-acquired pneumonia: A single center experience
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Evidence-based clinical algorithms for CAP: where do we stand?
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021
How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)?
Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia
Year: 2011
The assessment of physicians' knowledge of community-acquired pneumonia basics: KNOCAP study
Source: International Congress 2019 – Medical education
Year: 2019
HCAP: a new challenge
Source: Annual Congress 2009 - MP11 - Healthcare-associated pneumonia: a new challenge
Year: 2009
Clinical trials are important for CAP and other LRTI syndromes: but how to understand and interpret?
Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice
Year: 2010
Healthcare-associated pneumonia (HCAP): a new entity?
Source: Annual Congress 2008 - Infection year in review
Year: 2008
Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet?
Source: Eur Respir J 2013; 41: 5-6
Year: 2013
Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Mortality in COPD patients with community-acquired pneumonia: who is the third partner?
Source: Eur Respir J 2006; 28: 262-263
Year: 2006
Treating nosocomial pneumonia: what's new
Source: ERJ Open Res, 4 (2) 00058-2018; 10.1183/23120541.00058-2018
Year: 2018
PATS and ERS paediatric webinar: reducing the burden of CAP
Source: ERS webinar 2021: PATS and ERS paediatric webinar: reducing the burden of CAP
Year: 2021
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Late-breaking abstract: Clinical and radiological characteristics of cytomegalovirus pneumonia in immunocompromised patients
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011
Community-acquired pneumonia in pediatric patients: New diagnostic priorities
Source: Annual Congress 2012 - Asthma management
Year: 2012
Evaluation of guidelines for community-acquired pneumonia: a story of confounders, surprises and challenges
Source: Eur Respir J 2008; 32: 823-825
Year: 2008
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
ICU-acquired pneumonia and PaO2/FIO2 value accuracy: A new paradigm?
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept